Pancreatic Cancer Research

ResearcherUniversity of PittsburghActive in the last 2 years

Yangchun Xie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2571-4774; OpenAlex author ID A5057974824. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Ferroptosis in pancreatic ductal adenocarcinoma: Mechanisms, tumor biology, and therapeutic opportunities. Co-author DOI 10.1016/j.canlet.2026.218788↗
  2. AGER-dependent macropinocytosis drives resistance to KRAS-G12D-targeted therapy in advanced pancreatic cancer. Co-author DOI 10.1126/scitranslmed.adp4986↗
  3. MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.chembiol.2021.01.006↗
  4. Mitophagy in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.616079↗
  5. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer. First author DOI 10.1038/cr.2017.51↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rui Kang · 5 shared papers, 2017–2026 · strength 1.02
  2. Daolin Tang · 5 shared papers, 2017–2026 · strength 1.02
  3. Herbert J. Zeh · 2 shared papers, 2017–2025 · strength 0.30
  4. Changfeng Li · 1 shared paper, 2025 · strength 0.25
  5. Yuanda Liu · 1 shared paper, 2025 · strength 0.25
  6. Jiao Liu · 1 shared paper, 2025 · strength 0.25
  7. Fangquan Chen · 1 shared paper, 2025 · strength 0.25
  8. Feimei Kuang · 1 shared paper, 2021 · strength 0.17
  9. Jiao Liu · 1 shared paper, 2021 · strength 0.17
  10. David L. Bartlett · 1 shared paper, 2017 · strength 0.06
  11. Dexing Zeng · 1 shared paper, 2017 · strength 0.06
  12. Michael T. Lotze · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.